Creative Planning Alnylam Pharmaceuticals, Inc. Transaction History

Creative Planning

$101 Billion
Q3 2024

A detailed history of Creative Planning transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Creative Planning holds 10,012 shares of ALNY stock, worth $2.36 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,012

Previous 8,034 24.62%

Holding current value

$2.36 Million

Previous $1.95 Million 41.09%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 11, 2024	BUY	$233.81 - $287.01 $462,476 - $567,705	1,978 Added 24.62%	10,012 $2.75 Million
Q2 2024 Aug 15, 2024	BUY	$143.31 - $247.0 $445,694 - $768,170	3,110 Added 63.16%	8,034 $1.95 Million
Q1 2024 May 10, 2024	SELL	$146.51 - $198.2 $21,683 - $29,333	-148 Reduced 2.92%	4,924 $735,000
Q4 2023 Feb 14, 2024	BUY	$151.41 - $196.57 $143,990 - $186,938	951 Added 23.08%	5,072 $970,000
Q3 2023 Nov 16, 2023	SELL	$170.77 - $211.65 $142,592 - $176,727	-835 Reduced 16.85%	4,121 $729,000
Q2 2023 Jul 21, 2023	BUY	$185.01 - $212.05 $255,128 - $292,416	1,379 Added 38.55%	4,956 $941,000
Q1 2023 May 15, 2023	BUY	$182.66 - $235.53 $57,355 - $73,956	314 Added 9.62%	3,577 $716,000
Q4 2022 Feb 10, 2023	BUY	$185.53 - $241.31 $125,418 - $163,125	676 Added 26.13%	3,263 $775,000
Q3 2022 Nov 03, 2022	BUY	$138.54 - $232.0 $8,589 - $14,384	62 Added 2.46%	2,587 $518,000
Q2 2022 Aug 15, 2022	BUY	$120.42 - $169.29 $138,001 - $194,006	1,146 Added 83.1%	2,525 $368,000
Q1 2022 May 16, 2022	SELL	$127.18 - $173.91 $42,859 - $58,607	-337 Reduced 19.64%	1,379 $225,000
Q4 2021 Feb 11, 2022	BUY	$159.56 - $209.29 $39,570 - $51,903	248 Added 16.89%	1,716 $291,000
Q3 2021 Nov 10, 2021	BUY	$169.75 - $207.73 $249,193 - $304,947	1,468 New	1,468 $277,000
Q3 2019 Nov 01, 2019	SELL	$70.9 - $87.82 $1.5 Million - $1.86 Million	-21,194 Closed	0 $0
Q2 2019 Jul 26, 2019	BUY	$65.86 - $92.79 $1.4 Million - $1.97 Million	21,194 New	21,194 $1.54 Million

Others Institutions Holding ALNY

# of Institutions

641

Shares Held

109M

Call Options Held

1.28M

Put Options Held

1.21M

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $29B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.

Account

Creative Planning Alnylam Pharmaceuticals, Inc. Transaction History